BCR rearrangement-negative chronic myelogenous leukemia revisited

Journal of Clinical Oncology

Volumn 19, Issue 11, 2001, Pages 2915-2926

  Kurzrock, R ^a   Bueso Ramos, C E ^a   Kantarjian, H ^a   Freireich, E ^a   Tucker, S L ^a   Siciliano, M ^a   Pilat, S ^a   Talpaz, M ^a  

^a Box 302 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE REARRANGEMENT; HUMAN; LEUKEMOGENESIS; MALE; PATHOLOGIST; PRIORITY JOURNAL;

EID: 0035367160     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.11.2915     Document Type: Article

References (54)

1. A minute chromosome in human chronic granulocytic leukemia
2. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
3. The molecular genetics of Philadelphia chromosome-positive leukemias
4. The human cellular ABL gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity
5. An alternation of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
6. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia
7. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: Molecular analysis, clinical characteristics, and response to therapy
8. 1-negative CML patient
9. Genomic diversity correlates with clinical variation in Ph-negative chronic myeloid leukaemia
10. Do oncogenes determine clinical features in chronic myeloid leukaemia?
11. phl/ABL expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases
12. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): Comparison with Ph+ CML and chronic myelomonocytic leukemia
13. The chronic myeloid leukemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia - Proposals by the French-American-British Cooperative Leukemia Group
14. Philadelphia chromosome-negative chronic myelogenous leukemia without break-point cluster region rearrangement: A chronic myeloid leukemia with a distinct clinical course
15. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative"
16. Clonal nature of chronic neutrophilic leukemia
17. A case of chronic neutrophilic leukemia with trisomy 8
18. Chronic neutrophilic leukemia
19. Chronic neutrophilic leukemia: Case report documenting the absence of bcr-abl rearrangement
20. Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia
21. Chronic neutrophilic leukemia: A study of four cases
22. bcr Rearrangement in Ph-negative CML
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro
25. Neutrophilic chronic myeloid leukemia: A distinct disease with a specific molecular marker (BCR-ABL with C3/A2 junction)
26. Hybridization protection assay: A rapid, sensitive and specific method for detection for Philadelphia chromosome-positive leukemias
27. Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity
28. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients
29. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: Comparison with the frequency detected in cycling cells of the bone marrow
30. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia
31. Non-parametric estimation from incomplete observations
32. Chronic myelogenous leukemia and Sweet syndrome
33. Malignancy-associated Sweet's syndrome: Review of the world literature
34. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia
35. Haematological classification of the chronic myeloid leukaemias
36. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia
37. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein
38. Molecular diagnosis of Philadelphia-negative CML using the polymerase chain reaction and DNA analysis: Clinical features and course of M-bcr negative and M-bcr positive CML
39. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML
40. BCR-ABL gene variants
41. New type of BCR/ABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia
42. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction: Is it really a distinct disease?
43. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia
44. BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia
45. Bcr-Abl chronic myeloid leukaemia: The missing link with chronic myelomonocytic leukaemia?
46. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
47. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukemias
48. BCR/ABL transcripts and leukemia phenotype: An unsolved puzzle
49. Cross NCP: A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia
50. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia
51. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies
52. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
53. BCR-ABL mRNA lacking ABL exon a2 detected by polymerase chain reaction in a chronic myelogenous leukemia patient
54. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2